Integer (ITGR) Scheduled to Post Earnings on Thursday

Integer (NYSE:ITGR) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, April 25th. Analysts expect Integer to post earnings of $1.12 per share for the quarter. Integer has set its FY24 guidance at $5.01-5.43 EPS.Investors that wish to register for the company’s conference call can do so using this link.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, February 15th. The medical equipment provider reported $1.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.34 by $0.05. The firm had revenue of $413.15 million during the quarter, compared to analysts’ expectations of $409.04 million. Integer had a net margin of 5.68% and a return on equity of 10.80%. Integer’s revenue for the quarter was up 10.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.11 earnings per share. On average, analysts expect Integer to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Integer Stock Down 0.7 %

Integer stock opened at $118.49 on Thursday. The firm has a market cap of $3.97 billion, a price-to-earnings ratio of 44.05, a P/E/G ratio of 1.50 and a beta of 1.10. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.80 and a quick ratio of 1.71. Integer has a fifty-two week low of $69.40 and a fifty-two week high of $121.53. The firm has a fifty day moving average price of $111.36 and a two-hundred day moving average price of $98.08.

Institutional Trading of Integer

Several hedge funds have recently modified their holdings of ITGR. Cetera Advisor Networks LLC lifted its holdings in Integer by 2.4% in the fourth quarter. Cetera Advisor Networks LLC now owns 4,611 shares of the medical equipment provider’s stock valued at $457,000 after buying an additional 106 shares during the period. Creative Planning lifted its holdings in Integer by 5.4% in the third quarter. Creative Planning now owns 2,932 shares of the medical equipment provider’s stock valued at $230,000 after buying an additional 150 shares during the period. Tower Research Capital LLC TRC lifted its holdings in Integer by 28.5% in the first quarter. Tower Research Capital LLC TRC now owns 775 shares of the medical equipment provider’s stock valued at $60,000 after buying an additional 172 shares during the period. Public Employees Retirement System of Ohio lifted its holdings in Integer by 12.4% in the third quarter. Public Employees Retirement System of Ohio now owns 1,591 shares of the medical equipment provider’s stock valued at $99,000 after buying an additional 175 shares during the period. Finally, HighTower Advisors LLC lifted its holdings in Integer by 2.0% in the first quarter. HighTower Advisors LLC now owns 9,539 shares of the medical equipment provider’s stock valued at $740,000 after buying an additional 190 shares during the period. 99.29% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on ITGR. Bank of America raised shares of Integer from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $105.00 to $135.00 in a research report on Monday. KeyCorp upped their price objective on shares of Integer from $123.00 to $139.00 and gave the company an “overweight” rating in a research report on Tuesday, April 9th. CL King initiated coverage on shares of Integer in a research report on Thursday, March 14th. They set a “buy” rating and a $137.00 price objective for the company. Finally, Benchmark upped their price objective on shares of Integer from $105.00 to $130.00 and gave the company a “buy” rating in a research report on Thursday, March 28th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, Integer currently has a consensus rating of “Moderate Buy” and a consensus target price of $120.50.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.